Randomized Trial of High-Dose Chemotherapy and Blood Cell Autografts for High-Risk Primary Breast Carcinoma-Reference-Cited by-同舟云学术

Randomized Trial of High-Dose Chemotherapy and Blood Cell Autografts for High-Risk Primary Breast Carcinoma

Published:2000-02-02 Issue:3 Volume:92 Page:225-233
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Hortobagyi Gabriel N.,Buzdar Aman U.,Theriault Richard L.,Valero Vicente,Frye Debra,Booser Daniel J.,Holmes Frankie A.,Giralt Sergio,Khouri Issa,Andersson Borje,Gajewski James L.,Rondon Gabriela,Smith Terry L.,Singletary Sonja E.,Ames Frederick C.,Sneige Nour,Strom Eric A.,McNeese Marsha D.,Deisseroth Albert B.,Champlin Richard E.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/92/3/225/9996375/225.pdf

Reference43 articles.

1. Fisher ER, Fisher B. Relationship of pathologic and some clinical discriminants to the spread of breast cancer. Int J Radiat Oncol Biol Phys 1977;2:747-50.

2. Fisher ER, Redmond C, Fisher B. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol no. 4). VI. Discriminants for five-year treatment failure. Cancer 1980;46:908-18.

3. Buzdar AU, Gutterman JU, Blumenschein GR, Hortobagyi GN, Tashima CK, Smith TL, et al. Intensive postoperative chemoimmunotherapy for patients with stage II and stage III breast cancer. Cancer 1978;41:1064-75.

4. Hortobagyi GN, Ames FC, Buzdar AU, Kau SW, McNeese MD, Paulus D, et al. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer 1988;62:2507-16.

5. Buzdar AU, Kau SW, Smith TL, Hortobagyi GN. Ten-year results of FAC adjuvant chemotherapy trial in breast cancer. Am J Clin Oncol 1989;12:123-8.

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes;JAMA Oncology;2020-04-01

2. High-dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer;Cochrane Database of Systematic Reviews;2016-05-20

3. Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation;Bone Marrow Transplantation;2016-04-04

4. Autologous Hematopoietic Cell Transplantation for Breast Cancer and Germ-cell Tumors;Thomas’ Hematopoietic Cell Transplantation;2016-01-01

5. Unproven stem cell–based interventions and achieving a compromise policy among the multiple stakeholders;BMC Medical Ethics;2015-11-04